The Swedish Medical Products Agency has issued a license update authorizing the future manufacture and bioanalytical testing of Galderma’s proprietary investigational ready-to-use liquid botulinum ...
€2.1 billion bridge facility provided by a group of relationship banks
US$1 billion bank term loan facility to cover part of the financing requirements
Extension of existing €1.2 billion revol...
